Neuronetics
STIM----
Neuronetics (STIM)
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provid...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Neuronetics Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$4.50160.12%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 11 hours ago
The Unbundling of the Middle: Survival Strategies in the 2026 Market
- Global Report · 1 day ago, 04:13 AM
M&A, Poison Pills, and Capital Restructuring Drive US Mid-Cap Realignments
- Global Report · 2 days ago, 04:13 AM
Inside the Pegasystems Earnings Plunge: How Industrial and Tech Firms Are Footing the Bill for AI Expansion
- PUBT · Jul 23 at 03:06 PM
Neuronetics EVP, CFO Naor Nir files initial beneficial ownership statement
- Global Report · Jul 22 at 04:17 AM
Chime's Expansion and Jasper's M&A Deal Highlight Micro-Catalyst Driven US Market
- rttnews · Jul 20 at 10:01 PM
Top Biotech Gainers: ZYBT Skyrockets, ADVB Drops Planned Offering, STIM Gets New CFO, RDGT On Watch
